Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3

被引:24
|
作者
Huang, Chuhui [1 ]
Liew, Si Si [1 ]
Lin, Grace R. [1 ]
Poulsen, Anders [1 ]
Ang, Melgious J. Y. [1 ]
Chia, Brian C. S. [1 ]
Chew, Sin Yin [1 ]
Kwek, Zekui P. [1 ]
Wee, John L. K. [1 ]
Ong, Esther H. [1 ]
Retna, Priya [1 ]
Baburajendran, Nithya [1 ]
Li, Rong [1 ]
Yu, Weixuan [1 ]
Koh-Stenta, Xiaoying [1 ]
Ngo, Anna [1 ]
Manesh, Sravanthy [1 ]
Fulwood, Justina [1 ]
Ke, Zhiyuan [1 ]
Chung, Hwa Hwa [1 ]
Sepramaniam, Sugunavathi [1 ]
Chew, Xin Hui [1 ]
Dinie, Nurul [1 ]
Lee, May Ann [1 ]
Chew, Yun Shan [1 ]
Low, Choon Bing [1 ]
Pendharkar, Vishal [1 ]
Manoharan, Vithya [1 ]
Vuddagiri, Susmitha [1 ]
Sangthongpitag, Kanda [1 ]
Joy, Joma [1 ]
Matter, Alex [1 ]
Hill, Jeffrey [1 ]
Keller, Thomas H. [1 ]
Foo, Klement [1 ]
机构
[1] Expt Drug Dev Ctr, 10 Biopolis Rd 05-01 Chromos, Singapore 138670, Singapore
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2019年 / 10卷 / 06期
关键词
Epigenetics; Covalent; Irreversible; Methyltransferase; CELL-CULTURE; CANCER; INVASION; GROWTH; MODELS;
D O I
10.1021/acsmedchemlett.9b00170
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
SMYD3 is a histone methyltransferase that regulates gene transcription, and its overexpression is associated with multiple human cancers. A novel class of tetrahydroacridine compounds which inhibit SMYD3 through a covalent mechanism of action is identified. Optimization of these irreversible inhibitors resulted in the discovery of 4-chloroquinolines, a new class of covalent warheads. Tool compound 29 exhibits high potency by inhibiting SMYD3's enzymatic activity and showing antiproliferative activity against HepG2 in 3D cell culture. Our findings suggest that covalent inhibition of SMYD3 may have an impact on SMYD3 biology by affecting expression levels, and this warrants further exploration.
引用
收藏
页码:978 / 984
页数:13
相关论文
共 50 条
  • [31] Exploration of the Substrate Preference of Lysine Methyltransferase SMYD3 by Molecular Dynamics Simulations
    Sun, Jixue
    Shi, Fandi
    Yang, Na
    ACS OMEGA, 2019, 4 (22): : 19573 - 19581
  • [32] Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via HMGA2 transcription
    Gu, Wenchao
    Yang, Zongcheng
    Nakajima, Takahito
    CANCER SCIENCE, 2024, 115 : 782 - 782
  • [33] Discovery of a novel potent selective SMYD3 inhibitor with oral bioavailability
    Mitchell, Lorna
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [34] Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma
    Mai Thanh Binh
    Nghiem Xuan Hoan
    Dao Phuong Giang
    Hoang Van Tong
    Bock, C-Thomas
    Wedemeyer, Heiner
    Nguyen Linh Toan
    Mai Hong Bang
    Kremsner, Peter G.
    Meyer, Christian G.
    Le Huu Song
    Velavan, Thirumalaisamy P.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [35] Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma
    Mai Thanh Binh
    Nghiem Xuan Hoan
    Dao Phuong Giang
    Hoang Van Tong
    C.-Thomas Bock
    Heiner Wedemeyer
    Nguyen Linh Toan
    Mai Hong Bang
    Peter G. Kremsner
    Christian G. Meyer
    Le Huu Song
    Thirumalaisamy P. Velavan
    Scientific Reports, 10
  • [36] Conformational Dynamics of Lysine Methyltransferase Smyd2. Insights into the Different Substrate Crevice Characteristics of Smyd2 and Smyd3
    Chandramouli, Balasubramanian
    Chillemi, Giovanni
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (12) : 2467 - 2475
  • [37] Genotype analysis of the VNTR polymorphism in the SMYD3 histone methyltransferase gene:: Lack of correlation with the level of histone H3 methylation in NSCLC tissues or with the risk of NSCLC
    Barlesi, Fabrice
    Giaccone, Giuseppe
    Gallegos-Ruiz, Marielle I.
    Span, Simone W.
    Lefesvre, Pierre
    Kruyt, Frank A. E.
    Rodriguez, Jose Antonio
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (06) : 1441 - 1442
  • [38] SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways
    Bottino, Cinzia
    Peserico, Alessia
    Simone, Cristiano
    Caretti, Giuseppina
    CANCERS, 2020, 12 (01)
  • [39] Mutated KRAS Results in Overexpression of DUSP4, a MAP-Kinase Phosphatase, and SMYD3, a Histone Methyltransferase, in Rectal Carcinomas
    Gaedcke, Jochen
    Grade, Marian
    Jung, Klaus
    Camps, Jordi
    Jo, Peter
    Emons, Georg
    Gehoff, Anastasia
    Sax, Ulrich
    Schirmer, Markus
    Becker, Heinz
    Beissbarth, Tim
    Ried, Thomas
    Ghadimi, B. Michael
    GENES CHROMOSOMES & CANCER, 2010, 49 (11): : 1024 - 1034
  • [40] Cell geometry and the cytoskeleton impact the nucleo-cytoplasmic localisation of the SMYD3 methyltransferase
    Pereira, David
    Richert, Alain
    Medjkane, Souhila
    Henon, Sylvie
    Weitzman, Jonathan B.
    SCIENTIFIC REPORTS, 2020, 10 (01)